A zebrafish xenograft model for evaluating efficacy of cisplatin in muscle-invasive bladder cancer

被引：0
|
作者：
Sugino, Y. [1 ]
Sekito, S. [1 ]
Kageyama, T. [1 ]
Sasaki, T. [1 ]
Masui, S. [1 ]
Nishikawa, K. [1 ]
Tanaka, T. [2 ]
Shimada, Y. [3 ]
Zang, L. [4 ]
Inoue, T. [1 ]
机构：
[1] Mie Univ, Grad Sch Med, Dept Nephrourol Surg & Androl, Tsu, Mie, Japan
[2] Mie Univ, Grad Sch Med, Dept Syst Pharmacol, Tsu, Mie, Japan
[3] Mie Univ, Grad Sch Med, Dept Integrat Pharmacol, Tsu, Mie, Japan
[4] Mie Univ, Grad Sch Reg Innovat, Tsu, Mie, Japan
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P172
引用
收藏
页码：S241 / S242
页数：2
相关论文
共 50 条
  • [1] A zebrafish xenograft model for evaluating efficacy of cisplatin in muscle-invasive bladder cancer
    Sugino, Yusuke
    Sekito, Sho
    Kageyama, Takumi
    Sasaki, Takeshi
    Inoue, Takahiro
    Tanaka, Toshio
    CANCER SCIENCE, 2024, 115 : 1808 - 1808
  • [2] Retrospective analysis of the efficacy and safety of neoadjuvant gemcitabine and cisplatin in muscle-invasive bladder cancer
    Meleis, Laura
    Moore, Russell
    Inman, Brant A.
    Harrison, Michael R.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (02) : 330 - 337
  • [3] The Efficacy of Trimodal Chemoradiotherapy with Cisplatin as a Bladder-Preserving Strategy for the Treatment of Muscle-Invasive Bladder Cancer
    Nagao, Kazuhiro
    Hara, Takahiko
    Nishijima, Jun
    Shimizu, Kosuke
    Fujii, Nakanori
    Kobayashi, Keita
    Kawai, Yoshihisa
    Inoue, Ryo
    Yamamoto, Yoshiaki
    Matsumoto, Hiroaki
    Matsuyama, Hideyasu
    UROLOGIA INTERNATIONALIS, 2017, 99 (04) : 446 - 452
  • [4] Defining cisplatin eligibility in patients with muscle-invasive bladder cancer
    Jiang, Di Maria
    Gupta, Shilpa
    Kitchlu, Abhijat
    Meraz-Munoz, Alejandro
    North, Scott A.
    Alimohamed, Nimira S.
    Blais, Normand
    Sridhar, Srikala S.
    NATURE REVIEWS UROLOGY, 2021, 18 (02) : 104 - 114
  • [5] Defining cisplatin eligibility in patients with muscle-invasive bladder cancer
    Di Maria Jiang
    Shilpa Gupta
    Abhijat Kitchlu
    Alejandro Meraz-Munoz
    Scott A. North
    Nimira S. Alimohamed
    Normand Blais
    Srikala S. Sridhar
    Nature Reviews Urology, 2021, 18 : 104 - 114
  • [6] Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer
    Kaneko, Gou
    Kikuchi, Eiji
    Matsumoto, Kazuhiro
    Obata, Jun
    Nakamura, So
    Miyajima, Akira
    Oya, Mototsugu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 908 - 914
  • [7] Concurrent chemoradiotherapy with paclitaxel and cisplatin in muscle-invasive bladder cancer
    Wahab, R. Abdel
    Essa, H. H.
    Eltaher, A.
    Aboziada, M.
    Shehata, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [8] Muscle-invasive bladder cancer
    Kuebler, H.
    Gschwend, J. E.
    ONKOLOGE, 2012, 18 (11): : 977 - +
  • [9] Muscle-Invasive Bladder Cancer
    Hasan, Shaakir
    Chhabra, Arpit M.
    Choi, J. Isabelle
    Simone, Charles B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (01): : 309 - 310
  • [10] Muscle-invasive bladder cancer
    Buchler, Jakob
    Gschwend, Juergen E.
    Retz, Margitta
    Schmid, Sebastian C.
    UROLOGE, 2021, 60 (06): : 769 - 775
12345